All Recalls

95,114 total recalls in our database

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer

Apr 30, 2019 Prescription Drugs View Details →

Labeling: Label Error on Declared Strength: an artwork error on the secondary packaging of Relpax 40 mg Tablets, indicates that each tablet contains eletriptan hydrobromide equivalent to 20mg eletriptan, instead of 40mg, on one side of the carton.

Apr 29, 2019 Prescription Drugs Nationwide View Details →

CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

May 2, 2019 Prescription Drugs Nationwide View Details →

CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

May 2, 2019 Compounded Drugs Nationwide View Details →

The staplers may have an insufficient firing stroke to break the washer and completely form staples.

Apr 11, 2019 Diagnostic Equipment Nationwide View Details →

The staplers may have an insufficient firing stroke to break the washer and completely form staples.

Apr 11, 2019 Diagnostic Equipment Nationwide View Details →

Devices were delivered without the required dry ice.

Apr 9, 2019 Diagnostic Equipment View Details →

The staplers may have an insufficient firing stroke to break the washer and completely form staples.

Apr 11, 2019 Diagnostic Equipment Nationwide View Details →